AmeriTerpenes, LLC

AmeriTerpenes is the leading U.S.-based producer of natural, terpene-based ingredients and additives derived from renewable and by-product feedstocks, principally crude sulfate turpentine (CST) from pulp production and d-limonene from citrus processing. With around 170 employees and approximately USD 200 million in revenues, the company operates two integrated, well-invested production sites in Jacksonville, Florida, and Colonels Island, Georgia, serving customers across North America and internationally.

The portfolio comprises fragrance ingredients such as Dihydromyrcenol, Linalool, Citronellol and Geraniol, used in fine fragrances, beauty care, air care and household cleaning products; flavor ingredients including Anethole and its patented WS-Series range of menthol-derived cooling agents, used in oral care, confectionery and food and beverage applications; and bio-based solvents and additives serving industrial end-markets such as chemical processing, rubber manufacturing, cleaning and degreasing. Across all three areas, the company converts sustainably managed feedstocks and by-product streams into high-performance ingredients, offering customers natural alternatives to petrochemical-based products.

AmeriTerpenes is the largest producer of Dihydromyrcenol in North America and the only producer of Linalool and Anethole from renewable CST, holding leading market positions across its core products. This competitive positioning is supported by a diversified and resilient blue-chip customer base across key end-markets, including consumer goods, personal care, food and beverage and industrial chemicals, with many relationships spanning more than a decade.

Strategy

AmeriTerpenes’ strategy is to convert renewable and by-product feedstocks into high-performance natural ingredients that enable its customers to replace petrochemical-based additives in fragrance, flavor, personal care and industrial applications. The company’s priority for the coming years is to strengthen its commercial organization for international markets, win new customers across its target end-markets and cross-sell its broad ingredient portfolio into existing accounts, while expanding its innovation and development capabilities. In parallel, AmeriTerpenes is implementing a program of continuous improvement measures across both production sites to further raise operational efficiency, reliability and yields, building on the substantial investment made in its asset base in recent years.

The acquisition of AmeriTerpenes strengthens Mutares’ Chemicals & Materials segment and broadens the Group’s platform in specialty chemicals. Based on the Mutares value creation approach, the focus will be on operational excellence across the manufacturing platform and profitable growth through deeper penetration of long-standing customer relationships, a broader customer base and selective add-on acquisitions, further strengthening the company’s position as a partner of choice for natural, terpene-based ingredients.